Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
    Journal Article

    Sella, T.; Zheng, Y.; Tayob, N.; Ruddy, K. J.; Freedman, R. A.; Dang, C.; Yardley, D.; Isakoff, S. J.; Valero, V.; DeMeo, M.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline
    Guidelines

    Mao, J. J.; Ismaila, N.; Bao, T.; Barton, D.; Ben-Arye, E.; Garland, E. L.; Greenlee, H.; Leblanc, T.; Lee, R. T.; Lopez, A. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in HER2-positive metastatic breast cancer patients with brain metastases: A DESTINY-Breast01 subgroup analysis
    Journal Article

    Jerusalem, G.; Park, Y. H.; Yamashita, T.; Hurvitz, S. A.; Modi, S.; Andre, F.; Krop, I. E.; Farré, X. G.; You, B.; Saura, C.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Less, but better: A simplified design for T cell redirection and conditional payload delivery
    Editorial

    Kropp, K. N.; Klebanoff, C. A.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Primäre ergebnisse der TROPiCS-02: Eine randomisierte phase 3 studie mit sacituzumab govitecan vs. behandlung nach wahl des arztes (TPC) bei patienten mit hormonrezeptor-positivem/HER2-negativem (HR+/HER2-) fortgeschrittenem mammakarzinom
    Meeting Abstract

    Marmé, F.; Rugo, H. S.; Bardia, A.; Cortes, J.; Schmid, P.; Loirat, D.; Tredan, O.; Ciruelos, E.; Dalenc, F.; Gómez Pardo, P.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Delays in care following a COVID diagnosis
    Meeting Abstract

    Mullangi, S.; Aviki, E. M.; Chen, Y.; Robson, M. E.; Hershman, D. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Use of quality-of-life-related (QoL) eHealth interventions with Latino cancer patients during the pandemic: Findings from Latin America, United States, and Spain
    Meeting Abstract

    Costas-Muñiz, R.; Bergerot, C. D.; Castro-Figueroa, E. M.; Galindo, O.; Montana, F.; Esenarro, L.; Ruda-Santolaria, L.; Estape, T.; Sanchez-Ramirez, J. C.; Torres, N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cost effectiveness of adjuvant olaparib for BRCA-mutated, early-stage breast cancer
    Meeting Abstract

    Zettler, C.; De Silva, D.; Blinder, V. S.; Robson, M. E.; Elkin, E. B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identifying patient characteristics associated with chemotherapy-induced peripheral neuropathy (CIPN) severity in a phase II clinical trial: A retrospective analysis
    Meeting Abstract

    Zhi, W. I.; Dreyfus, N.; Dooley, A.; Piulson, L.; Li, Q. S.; Bao, T.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Warner, A. B.; Yu, H. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save